Trials / Conditions / Acute Alcoholic Hepatitis

Acute Alcoholic Hepatitis

9 registered clinical trials studyying Acute Alcoholic Hepatitis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial NCT06285253	Miromatrix Medical Inc.	Phase 1
Not Yet Recruiting	MRG-001 in Patients With Alcoholic Hepatitis NCT06307522	MedRegen LLC	Phase 2
Recruiting	Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HP NCT07262515	Assistance Publique - Hôpitaux de Paris	—
Terminated	Digoxin In Treatment of Alcohol Associated Hepatitis NCT05014087	Yale University	Phase 2
Terminated	Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjec NCT02612428	Vital Therapies, Inc.	Phase 3
Completed	Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic NCT01809132	Mack Mitchell	Phase 2 / Phase 3
Terminated	Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF NCT01937130	Conatus Pharmaceuticals Inc.	Phase 2
Terminated	Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis NCT01922895	University of Texas Southwestern Medical Center	N/A
Completed	Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver NCT01471028	Vital Therapies, Inc.	Phase 3